Company intelligence / Profile preview

NeuroScientific Biopharmaceuticals

Cottesloe, Western Australia, Australianeuroscientific.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

NeuroScientific Biopharmaceuticals has reported promising preclinical data for its lead peptide drug candidate, EmtinB, showing neuroprotective and neuroregenerative effects in models of Alzheimer’s disease and other neurodegenerative conditions. The company claims breakthrough results suggesting potential for disease-modifying therapy in Alzheimer's and significant promise in other indications such as multiple sclerosis, glaucoma, optic neuropathies, ALS, spinal injury, and Parkinson's disease. No clinical trial results have been published yet.

Therapeutic areas
OphthalmologyNeurology
Modalities
PeptidesPeptide-based drug
Industry
Biotech
02

Drug pipeline

1 asset

StemSmart

Unknown
03

Partnerships

Covance – preclinical studies partnerLion's Eye Institute – ophthalmology research partnerMenzies Institute for Medical Research – neuroscience research collaboration

Beyond the preview

Go deeper on NeuroScientific Biopharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeuroScientific Biopharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call